Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial - Mateos, MV; Engelhardt, M; Leleu, X (Eur J Haematol, 2024)